Hu Yunzhen, Cao Meiling, Xu Danhua, Wang Jianwen, Lu Xiaoyang
Int J Clin Pharmacol Ther. 2016 Aug;54(8):581-6. doi: 10.5414/CP202462.
A prospective observational study of clinical pharmacist interventions was conducted over a 2-year period from November 2012 to October 2014 to evaluate the clinical activity of pharmacists in the care they provide to patients and to promote safe and effective medication therapy by quantifying medicine-related interventions on a Chinese neurology ward. All pharmacist interventions made in the department of neurology were recorded, categorized, and assessed for potential patient harm if the intervention had not taken place. The quantity, outcomes, and potential severity of clinical pharmacists' interventions were recorded. 619 interventions were made in 385 patients over the 2-year observational period. The mean severity of potential harm assessment was 3.7 (1.12), range 0.8 - 7.0. 87 of the 619 interventions (14.0%) were classified as medication errors. The results of the clinical pharmacist intervention study demonstrated that pharmacists play an important role in the care of neurological patients by improving patient care and reducing clinical risk.
2012年11月至2014年10月的两年期间，开展了一项关于临床药师干预措施的前瞻性观察性研究，以评估药师在为患者提供护理过程中的临床活动，并通过对中国某神经内科病房与药物相关的干预措施进行量化，促进安全有效的药物治疗。记录了神经内科所有药师的干预措施，进行分类，并评估了若未进行干预对患者可能造成的伤害。记录了临床药师干预措施的数量、结果及潜在严重程度。在为期两年的观察期内，对385名患者进行了619次干预。潜在伤害评估的平均严重程度为3.7（标准差1.12），范围为0.8至7.0。619次干预中有87次（14.0%）被归类为用药差错。临床药师干预研究结果表明，药师通过改善患者护理和降低临床风险，在神经科患者护理中发挥着重要作用。
